MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] MedG ...

CervoMed ( ($CRVO) ) has shared an announcement. On November 4, 2025, CervoMed Inc. announced it received alignment from the U.S. FDA on key ...

The collaboration will strengthen Endeavor Health’s specialised, coordinated and accessible care for migraine treatment.

According to Mishra, the bacterial communities that establish in the first six to 12 months are responsible for allergy risk, ...

Palantir’s “ascent has confounded most financial analysts and the chattering class, whose frames of reference did not quite ...

Hohenstein Medical ? a division of Hohenstein Laboratories and a leading provider of testing, research and certification services for medical devices ? has hired Katie Brinkman as its biocompatibility ...

FDA feedback enables CervoMed to proceed with proposed endpoints, patient enrichment strategy, and other key aspects of Phase 3 trial design to support potential New Drug Application CervoMed is ...

Former NBA Player Tells Rutgers Health Students How He Rebounded From a Speech Impediment When former NBA player Michael Kidd-Gilchrist stepped into the classroom at Rutgers School of Health ...

The partnership combines MedGenome’s multiomics capabilities with Green Cross’s laboratory network to enhance access to ...

From Dalit-led initiatives to trauma-informed networks, these seven organisations are not just offering therapy, but building ...

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

Bengaluru (Karnataka) [India], November 4: MedGenome, a leading global genomics-driven diagnostics and research services company, has announced a majority investment in Gujarat-headquartered pathology ...